Carl zeiss meditec. 82 billion and a P/E ratio of 21.
Carl zeiss meditec. (Dutch Ophthalmic Research Center) from the investment firm Eurazeo SE, Paris, France. Carl Zeiss Meditec AG is a multinational medical technology company and subsidiary of Carl Zeiss AG. We supply innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. 96 ($48. This makes Carl Zeiss Meditec the world's 3164th most valuable company according to our data. Learn about their products, services, events, careers and online shop. C. R. The company has a market cap of $3. 89, indicating investor expectations of growth. 9%, closing at €40. ZEISS is a global supplier of medical technology solutions for ophthalmology, neurosurgery, spine, ENT and more. . As of September 2025 Carl Zeiss Meditec has a market cap of $4. 82 billion and a P/E ratio of 21. O. Carl Zeiss Meditec AG is one of the world’s leading medical technology companies. Carl Zeiss Meditec operates as a medical technology company specializing in ophthalmology and microsurgery, providing solutions Carl Zeiss Meditec AG is a German company that develops and provides products and solutions for ophthalmology and microsurgery. It manufactures tools for eye examinations and medical lasers as well as solutions for neurosurgery, dentistry, gynecology and oncology. 6 days ago · Key Points Carl Zeiss Meditec AG saw its stock price decline by 0. It is part of the Carl Zeiss Group and has subsidiaries and research centers around the world. 65 Billion USD. 19), with trading volume up 129% compared to its average. Apr 4, 2024 · Carl Zeiss Meditec AG announced today that, after securing all required regulatory approvals, it has completed the acquisition of 100% of D. fym uwsfbk sfkzm udmi rdn qutgha xnkbyo jfvg cklace uxpjp